ViaCyte's Convertible Note Round

ViaCyte raised a round of funding on August 25, 2014. Investors include Johnson & Johnson Innovation.

ViaCyte, a private company that has emerged as a provider in the field of regenerative medicine, is focused on developing a novel therapy for the treatment of diabetes. The Company's lead product is b…

Articles about ViaCyte's Convertible Note Round: